AI in drug discovery and its clinical relevance
Rizwan Qureshi(Unknown), Tanvir Alam(Hamad bin Khalifa University), Muhammad Irfan(European University of Lefke), Sheheryar Khan(Hong Kong Polytechnic University), John V. Heymach(The University of Texas MD Anderson Cancer Center), Muhammad Usman Hadi(University of Ulster), Taimoor Muzaffar Gondal(Superior University), Jia Wu(The University of Texas MD Anderson Cancer Center), Hong Yan(Nanjing Medical University), Xiuning Le(The University of Texas MD Anderson Cancer Center)
Cited by 271
Related Papers
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
|Nature Medicine|2011|1.4k
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
|Journal of Clinical Oncology|2019|1.3k
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
|The Lancet Oncology|2016|1.1k
An atlas of human long non-coding RNAs with accurate 5′ ends
|Nature|2017|1.1k